Nitric oxide and beta2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice

S. Shinomiya, T. Shibamoto, S. Mizuno, K. Osanai, H. Toga (Kanazawa, Japan)

Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Session: Pulmonary circulation: animal models and experimental treatments
Session type: Poster Discussion
Number: 495
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Shinomiya, T. Shibamoto, S. Mizuno, K. Osanai, H. Toga (Kanazawa, Japan). Nitric oxide and beta2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice. Eur Respir J 2013; 42: Suppl. 57, 495

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2009; 34: 731
Year: 2009



Lung allergic inflammation and stress: effects of capsaicin neonatal treatment on pulmonary mechanics and exhaled nitric oxide in stressed rats
Source: Eur Respir J 2002; 20: Suppl. 38, 105s
Year: 2002

Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015


Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Comparative effects of inhaled nitric oxide and aerosolized iloprost during vasoreactivity testing in chronic pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 561s
Year: 2005

Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
Source: Eur Respir J 2003; 21: 19-24
Year: 2003



Blunted effects of rho-kinase inhibitor, fasudil, on pulmonary arterial pressure in Yak, a high altitude-adapted animal
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013

Inhaled vasodilators in acute lung injury
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=129
Year: 2002

Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016


Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice
Source: Eur Respir J 2002; 20: 177-182
Year: 2002



Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Infused nitric oxide in experimental pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007

Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Inhaled INS1009 demonstrates localized pulmonary vasodilation activity
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Chronic nitric oxide inhibition increases airway remodeling in guinea pigs with lung inflammation
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Hemodynamic effects of different vasodilators in patients with type II pulmonary hypertension (PH)
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014